Parkinson's disease (PD) is one of the most common chronic neurological diseases and one of the significant causes of disability for middle-aged and elderly people. Monitoring the patient's condition and its compliance is the key to the success of the correction of the main clinical manifestations of PD, including the almost inevitable modification of the clinical picture of the disease against the background of prolonged dopaminergic therapy. In this article, we proposed an approach to assessing the condition of patients with PD using deep recurrent neural networks, trained on data measured using mobile phones. The data was received in two modes: background (data from the phone's sensors) and interactive (data directly entered by the user). For the classification of the patient's condition, we built various models of the neural network. Testing of these models showed that the most efficient was a recurrent network with two layers. The results of the experiment show that with a sufficient amount of the training sample, it is possible to build a neural network that determines the condition of the patient according to the data from the mobile phone sensors with a high probability.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235735PMC
http://dx.doi.org/10.3390/diagnostics10040214DOI Listing

Publication Analysis

Top Keywords

parkinson's disease
8
neural networks
8
mobile phone
8
phone sensors
8
patient's condition
8
neural network
8
data
5
assessment status
4
status patients
4
patients parkinson's
4

Similar Publications

Introduction: Intraoperative microelectrode recording (MER) and intraoperative test stimulation may provide vital information for optimal electrode placement and clinical outcome in movement disorders patients treated with deep brain stimulation (DBS). The aims of this retrospective study were to determine (i) how often the planned (imaging based) placements of electrodes were changed due to MER and intraoperative test stimulation in Parkinson's disease (PD), dystonia and essential tremor (ET) patients; (ii) whether the frequency of repositioning changed over time; (iii) whether patients' age or disease duration (in PD) influenced the frequency of repositioning.

Methods: Data on the planned and the final placement of 141 electrodes in 72 consecutive DBS treated patients (52 PD, 11 dystonia, 9 ET) was collected over the first 8 years of DBS implementation in a single center.

View Article and Find Full Text PDF

Mitochondria and lysosomes are critical for neuronal homeostasis, as highlighted by their dysfunction in various neurological diseases. Recent studies have identified dynamic membrane contact sites between mitochondria and lysosomes, independent of mitophagy and the lysosomal degradation of mitochondrial-derived vesicles (MDVs), allowing bidirectional crosstalk between these cell compartments, the dynamic regulation of organelle networks, and substance exchanges. Emerging evidence suggests that abnormalities in mitochondria-lysosome contact sites (MLCSs) contribute to neurological diseases, including Parkinson's disease, Charcot-Marie-Tooth (CMT) disease, lysosomal storage diseases, and epilepsy.

View Article and Find Full Text PDF

Transcutaneous vagus nerve stimulation for Parkinson's disease: a systematic review and meta-analysis.

Front Aging Neurosci

January 2025

Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Background: Transcutaneous vagus nerve stimulation (tVNS) has emerged as a novel noninvasive adjunct therapy for advanced Parkinson's disease (PD), yet no quantitative analysis had been conducted to assess its therapeutic effect.

Objectives: This review aimed to investigate the efficacy of tVNS on motor function, other potential clinical targets and its safety in various treatment conditions.

Methods: We searched six databases for randomized controlled trials (RCTs) that involved treating PD patients with tVNS.

View Article and Find Full Text PDF

The gradually increasing age of the world population implies that the prevalence of neurodegenerative diseases also continues to rise. These diseases are characterized by a progressive loss of cognitive and motor functions. Parkinson's disease, which involves the gradual death of specialized neural tissue, is a striking example of a neurodegenerative process.

View Article and Find Full Text PDF

Brain Age as a New Measure of Disease Stratification in Huntington's Disease.

Mov Disord

January 2025

School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, Victoria, Australia.

Background: Despite advancements in understanding Huntington's disease (HD) over the past two decades, absence of disease-modifying treatments remains a challenge. Accurately characterizing progression states is crucial for developing effective therapeutic interventions. Various factors contribute to this challenge, including the need for precise methods that can account for the complex nature of HD progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!